|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn947837559 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160104s2016 nyua ob 001 0 eng |
| 010 |
|
|
|a 2020687445
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d OCLCF
|d EBLCP
|d YDX
|d SNK
|d DKU
|d IGB
|d D6H
|d VTS
|d AGLDB
|d G3B
|d S8J
|d S9I
|d STF
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781634846424
|q (ebook)
|
| 020 |
|
|
|a 1634846427
|
| 020 |
|
|
|z 9781634846240
|q (hardback)
|
| 029 |
1 |
|
|a AU@
|b 000062420394
|
| 035 |
|
|
|a (OCoLC)947837559
|
| 050 |
0 |
0 |
|a RC685.M9
|
| 060 |
|
4 |
|a WG 210
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.1/24
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Takotsubo cardiomyopathy :
|b risk factors, management and long-term outlook /
|c Marvin Lynch, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical/Nova Science Publishers, Inc.,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Cardiology research and clinical developments
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record and CIP data provided by publisher.
|
| 505 |
0 |
|
|a TAKOTSUBO CARDIOMYOPATHY RISK FACTORS, MANAGEMENT AND LONG-TERM OUTLOOK ; TAKOTSUBO CARDIOMYOPATHY RISK FACTORS, MANAGEMENT AND LONG-TERM OUTLOOK ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 TAKOTSUBO CARDIOMYOPATHY: PATHOGENESIS, NATURAL HISTORY AND PROGNOSIS ; ABSTRACT ; INTRODUCTION ; PATHOGENESIS ; RISK FACTORS ; Epidemiology ; Physical and Emotional Triggers ; MANAGEMENT ; Diagnosis ; Natural History and Complications ; PROGNOSIS ; Short-Term Prognosis ; Long-Term Prognosis ; CONCLUSION ; Conflict of Interest ; REFERENCES
|
| 505 |
8 |
|
|a Chapter 2 REVERSIBLE LEFT VENTRICULAR DYSFUNCTION: A REVIEW OF RISK FACTORS, MANAGEMENT AND PROGNOSIS ABSTRACT ; RISK FACTORS; MANAGEMENT; Treatment in Acute Phase ; Treatment in Chronic Phase; Management of Complications ; Congestive Heart Failure/Cardiogenic Shock ; Apical Thrombosis ; Arrhythmias ; Mechanical Complications ; LONG-TERM OUTLOOK ; Prognosis Based on the Complications ; Arrhythmias ; Congestive Heart Failure/Cardiogenic Shock ; Apical Thrombosis; Mechanical Complications ; Takotsubo in Ill Critical Patient ; Predictors of Short and Long-Term
|
| 505 |
8 |
|
|a Mortality in Takotsubo Cardiomyopathy Recurrence ; REFERENCES ; BIOGRAPHICAL SKETCH; Chapter 3 PERSONALITY TRAITS THAT MAKE VULNERABLE TO TAKOTSUBO CARDIOMYOPATHY ; ABSTRACT ; 1. INTRODUCTION; 2. WHICH PERSONALITY TRAITS MAKE VULNERABLE TO TAKOTSUBO CARDIOMYOPATHY? ; Type D Distressed Personality ; Scientific Evidence about the Link between Type D Personality and Takotsubo Cardiomyopathy ; 3. HOW TYPE D PERSONALITY MAKE VULNERABLE TO TAKOTSUBO CARDIOMYOPATHY? ; Biological Mechanism ; Behavioral Mechanism ; 4. PSYCHOLOGICAL FACTORS INVOLVED IN TAKOTSUBO CARDIOMYOPATHY
|
| 505 |
8 |
|
|a Emotional Regulation Stress Management ; Mood and Anxiety Disorders ; CONCLUSION ; REFERENCES ; Chapter 4 ARRHYTHMIAS IN TAKOTSUBO CARDIOMYOPATHY: INCIDENCE, PROGNOSIS AND MANAGEMENT; ABSTRACT ; INTRODUCTION ; ARRHYTHMIAS IN TAKOTSUBO CARDIOMYOPATHY ; TACHYARRHYTHMIAS ; Supraventricular Arrhythmias ; Atrial Fibrillation and Atrial Flutter ; Pathophysiology ; Management ; Ventricular Arrhythmia ; Ventricular Tachycardia (VT) and Ventricular Fibrillation (VF) ; Pathophysiology ; Management ; BRADYARRHYTHMIAS ; Supraventricular Arrhythmias; Sinus Node and Atrio-Ventricular Nodal Dysfunction
|
| 505 |
8 |
|
|a Pathophysiology Management ; Ventricular Arrhythmias ; Ventricular Asystole ; Management ; PROGNOSIS ; CONCLUSION ; REFERENCES ; BIOGRAPHICAL SKETCHES ; Chapter 5 BIOMARKERS IN TAKOTSUBO CARDIOMYOPATHY ; ABSTRACT ; 1. INTRODUCTION ; Data About TTC, Relevant to Biomarker Considerations; 1.1. Pathophysiology ; 1.2. TTC Triggers ; 2. BIOMARKERS IN TTC (FOR DIAGNOSIS) ; 2.1. Rationale for Biomarkers Use in TTC ; 2.2. Cardiac Troponin in TTC; 2.2.1. Troponin -- A Crucial Biomarker ; 2.2.2. Troponin -- Not so Elevated in TTC ; 2.2.3. Troponin and TTC in Important Primary Non-Cardiac Diseases
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Myocardium
|x Diseases.
|
| 650 |
|
2 |
|a Takotsubo Cardiomyopathy
|
| 650 |
|
2 |
|a Cardiomyopathies
|
| 650 |
|
6 |
|a Cardiomyopathies.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Myocardium
|x Diseases
|2 fast
|
| 700 |
1 |
|
|a Lynch, Marvin,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Takotsubo cardiomyopathy
|d New York : Nova Biomedical, [2016]
|z 9781634846240 (hardback)
|w (DLC) 2016930013
|
| 830 |
|
0 |
|a Cardiology research and clinical developments series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1226150
|z Texto completo
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1226150
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4586683
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12820950
|
| 994 |
|
|
|a 92
|b IZTAP
|
